JBM (Healthcare) Limited (HKG:2161)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.800
+0.090 (3.32%)
Mar 10, 2026, 3:57 PM HKT
54.70%
Market Cap 2.21B
Revenue (ttm) 812.98M
Net Income (ttm) 216.39M
Shares Out 817.30M
EPS (ttm) 0.25
PE Ratio 11.01
Forward PE 9.22
Dividend 0.20 (7.20%)
Ex-Dividend Date Nov 28, 2025
Volume 270,000
Average Volume 290,084
Open 2.730
Previous Close 2.710
Day's Range 2.730 - 2.800
52-Week Range 1.470 - 3.430
Beta 0.35
RSI 54.33
Earnings Date Feb 16, 2026

About JBM (Healthcare)

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes... [Read more]

Sector Healthcare
Founded 2020
Employees 412
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2161
Full Company Profile

Financial Performance

In fiscal year 2025, JBM (Healthcare)'s revenue was 782.29 million, an increase of 20.65% compared to the previous year's 648.42 million. Earnings were 197.26 million, an increase of 51.20%.

Financial Statements

News

There is no news available yet.